Cargando…
A refined and updated health impact assessment of the Global Programme to Eliminate Lymphatic Filariasis (2000–2020)
BACKGROUND: Lymphatic filariasis (LF) is a neglected tropical disease (NTD). In 2000 the World Health Organization (WHO) established the Global Programme to Eliminate Lymphatic Filariasis (GPELF). A key component of this programme is mass drug administration (MDA). Between 2000 and 2020, the GPELF h...
Autores principales: | Turner, Hugo C., Ottesen, Eric A., Bradley, Mark H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148484/ https://www.ncbi.nlm.nih.gov/pubmed/35643508 http://dx.doi.org/10.1186/s13071-022-05268-w |
Ejemplares similares
-
The health and economic benefits of the global programme to eliminate lymphatic filariasis (2000–2014)
por: Turner, Hugo C., et al.
Publicado: (2016) -
Setting the stage for a Global Programme to Eliminate Lymphatic Filariasis: the first 125 years (1875–2000)
por: Ottesen, Eric A, et al.
Publicado: (2020) -
The Global Programme to Eliminate Lymphatic Filariasis: Health Impact after 8 Years
por: Ottesen, Eric A., et al.
Publicado: (2008) -
The Economic Benefits Resulting from the First 8 Years of the Global Programme to Eliminate Lymphatic Filariasis (2000–2007)
por: Chu, Brian K., et al.
Publicado: (2010) -
Global Programme to Eliminate Lymphatic Filariasis: The Processes Underlying Programme Success
por: Ichimori, Kazuyo, et al.
Publicado: (2014)